Renal function in Wilson's disease.
作者信息
BEARN A G, YU T F, GUTMAN A B
出版信息
J Clin Invest. 1957 Jul;36(7):1107-14. doi: 10.1172/JCI103506.
Abstract
摘要
相似文献
1
Renal function in Wilson's disease.
J Clin Invest. 1957 Jul;36(7):1107-14. doi: 10.1172/JCI103506.
2
Some aspects of kidney function in hepatolenticular degeneration (Wilson's disease).
J Lab Clin Med. 1956 Mar;47(3):337-42.
3
The electroencephalogram in hepatolenticular degeneration (Wilson's disease).
Electroencephalogr Clin Neurophysiol. 1962 Aug;14:520-6. doi: 10.1016/0013-4694(62)90056-1.
4
[On the pathogenesis and therapy of Wilson's disease. The effect of alpha-lipoic acid (preliminary communication)].
Arzneimittelforschung. 1960 May;10:333-9.
5
[Renal function disorders in congenital metabolic abnormalities. 1. Renal function disorders in Wilson's disease].
Nihon Shonika Gakkai Zasshi. 1971 Jun;75(6):454-63.
6
[Renal function & excretion of 17-ketosteroids in hepatolenticular degeneration].
Neurol Neurochir Psychiatr Pol. 1957 Sep-Oct;7(5):725-38.
7
Renal tubule and Wilson's disease.
Ann Intern Med. 1972 May;76(5):835-6. doi: 10.7326/0003-4819-76-5-835_2.
8
[Distal renal tubular acidosis in patients with Wilson's disease].
Sb Lek. 1991 Oct;93(9-10):315-23.
9
[On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
Acta Neurol (Napoli). 1971 Jul-Aug;26(4):423-35.
10
Hepatolenticular degeneration--is the term too narrow to explain Wilson's disease?
J Assoc Physicians India. 2014 Jun;62(6):531-3.
引用本文的文献
1
Kidney involvement in Wilson's disease: a review of the literature.
Clin Kidney J. 2024 Mar 9;17(4):sfae058. doi: 10.1093/ckj/sfae058. eCollection 2024 Apr.
2
Plasmapheresis for Fulminant Wilson's Disease Improves Mental Status and Coagulopathy.
Case Reports Hepatol. 2023 Jun 19;2023:3985823. doi: 10.1155/2023/3985823. eCollection 2023.
3
Wilson disease: a diagnostic challenge in a patient with alcoholic liver disease.
BMJ Case Rep. 2019 Oct 25;12(10):e232449. doi: 10.1136/bcr-2019-232449.
4
Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease.
Clin Biochem Rev. 2019 May;40(2):59-77. doi: 10.33176/AACB-18-00014.
5
Clinical manifestations of Wilson disease in organs other than the liver and brain.
Ann Transl Med. 2019 Apr;7(Suppl 2):S62. doi: 10.21037/atm.2019.03.30.
6
Renal impairment in different phenotypes of Wilson disease.
Neurol Sci. 2015 Nov;36(11):2111-5. doi: 10.1007/s10072-015-2322-y. Epub 2015 Jul 29.
7
Penicillamine neurotoxicity: an hypothesis.
ISRN Neurol. 2011;2011:464572. doi: 10.5402/2011/464572. Epub 2011 Jul 21.
8
9
Wilson's disease presenting as respiratory failure.
Indian J Pediatr. 2006 Jan;73(1):99-100. doi: 10.1007/BF02758271.
10
On the mechanism of acidosis in chronic renal disease.
J Clin Invest. 1959 Jan 1;38(1, Part 1):39-52. doi: 10.1172/JCI103794.
本文引用的文献
1
INVESTIGATION OF THE AMINOACIDURIA IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION): DEMONSTRATION OF A DEFECT IN RENAL FUNCTION.
J Clin Invest. 1950 Mar;29(3):265-78. doi: 10.1172/JCI102254.
2
THE RENAL REGULATION OF ACID-BASE BALANCE IN MAN. III. THE REABSORPTION AND EXCRETION OF BICARBONATE.
J Clin Invest. 1949 Jan;28(1):35-44. doi: 10.1172/JCI102050.
3
Functional characteristics of transport mechanisms.
J Pharmacol Exp Ther. 1950 Aug;99(4:2):227-80.
4
Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects.
J Clin Invest. 1952 Jul;31(7):692-701. doi: 10.1172/JCI102651.
5
'Benemid,' p-(di-n-propylsulfamyl)-benzoic acid; its renal affinity and its elimination.
Am J Physiol. 1951 Sep;166(3):625-40. doi: 10.1152/ajplegacy.1951.166.3.625.
6
Uric acid metabolism in hepatolenticular degeneration.
Proc Soc Exp Biol Med. 1955 Mar;88(3):427-30. doi: 10.3181/00379727-88-21608.
7
The adult Fanconi syndrome. II. Review of eighteen cases.
Am J Med. 1957 Jan;22(1):13-23.
8
Some aspects of kidney function in hepatolenticular degeneration (Wilson's disease).
J Lab Clin Med. 1956 Mar;47(3):337-42.
9
Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration.
J Clin Invest. 1955 Dec;34(12):1766-78. doi: 10.1172/JCI103232.
10
Copper metabolism in Wilson's disease.
Trans Assoc Am Physicians. 1954;67:232-41.
Zotero 插件